⌘K

Login Start Free

Home/Filings/4/0001209191-22-023745

4//SEC Filing

Trainer John 4

Accession 0001209191-22-023745

CIK 0001538210other

View on SEC.gov Company Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 7:11 PM ET

Size

5.4 KB

Accession

0001209191-22-023745

Insider Transaction Report

Form 4

Period: 2022-04-05

NexImmune, Inc.NEXI

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2022-04-05+78,100→ 78,100 total
Exercise: $4.22Exp: 2032-04-04→ Common Stock (78,100 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Trainer's continued service to the corporation on each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1

filerCIK 0001843820

Filing Metadata

Form type: 4
Filed: Apr 6, 8:00 PM ET
Accepted: Apr 7, 7:11 PM ET
Size: 5.4 KB

View on SEC.gov